Improved synthesis and biological evaluation of Tc‐99m radiolabeled AMO for miRNA imaging in tumor xenografts

E-ISSN： 1099-1344|58|13-14|461-468

ISSN： 0362-4803

Source： JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS (ELECTRONIC), Vol.58, Iss.13-14, 2015-11, pp. : 461-468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

MicroRNAs (miRNAs) have been considered as important biomarkers for malignant tumors. In this study, we introduced an improved 99mTc labeling method for noninvasive visualization of overexpressed miRNAs in tumor‐bearing mice. Anti‐miRNA‐21 oligonucleotide (AMO) with partial 2′‐O‐methyl and phosphorothioate modification was designed and chemically synthesized. After conjugated with NHS‐MAG3, AMO was labeled with 99mTc. Optimization was made to shorten reaction time and to improve labeling efficiency. Labeling efficiency was 97%, and specific activity was 2.78 MBq/ng. During 12 h, 99mTc‐AMO showed no significant degradation by gel electrophoresis. Its radiochemical purity was stable, between 95.8% and 99.1%. Further, 99mTc‐AMO decreased the level of miR‐21 and increased the expression of PTEN protein at cellular level, shown by qRT‐PCR and Western blot. Fluorescent protein labeled AMO displayed specific distribution and good stability in tumor cells. After the administration in tumor‐bearing mice, 99mTc‐AMO showed more radioactive uptake in the miR‐21 over‐expressed tumors than scramble control. Biodistribution results further proved the significant difference of tumor uptake between 99mTc‐AMO and 99mTc‐control. Therefore, this study presents an improved method with shorten time to prepare a 99mTc radiolabeled AMO. In addition, it supports the role of 99mTc‐AMO for noninvasive visualization of miR‐21 in malignant tumors.